Medfinder
Back to blog

Updated: January 25, 2026

What Is Incruse Ellipta? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Incruse Ellipta inhaler with information icon representing a complete drug guide

New to Incruse Ellipta? This complete 2026 guide covers what it treats, how to use it, dosage, side effects, cost, and answers to the most common patient questions.

Incruse Ellipta is a prescription inhaler used every day to help people with COPD breathe more easily. If you've just been prescribed it for the first time — or you're trying to learn more before your next doctor's appointment — this guide answers the most important questions: what it is, what it treats, how to use it, and what to expect.

What Is Incruse Ellipta?

Incruse Ellipta is the brand name for umeclidinium inhalation powder, a prescription medication manufactured by GlaxoSmithKline (GSK). It was first approved by the FDA in 2013 and is delivered via the Ellipta dry powder inhaler device — a light grey and light green plastic inhaler containing a pre-loaded strip of 30 foil-sealed powder blisters.

Each blister delivers 62.5 mcg of umeclidinium upon inhalation. Umeclidinium is classified as a long-acting muscarinic antagonist (LAMA) — a type of anticholinergic bronchodilator that keeps the airways open by relaxing the smooth muscles surrounding them.

What Does Incruse Ellipta Treat?

Incruse Ellipta is FDA-approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. COPD is a group of chronic lung diseases that includes:

  • Chronic bronchitis: Long-term inflammation and narrowing of the bronchial tubes with persistent cough and mucus production.
  • Emphysema: Damage to the air sacs (alveoli) in the lungs, reducing the surface area for oxygen exchange and causing breathlessness.

Incruse Ellipta is used for long-term maintenance — meaning you take it every day to reduce symptoms and prevent exacerbations. It is

not a rescue inhaler and will not help if you're having a sudden COPD attack or breathing emergency. Always keep a fast-acting rescue inhaler (like albuterol) available for emergencies.

How Do You Use Incruse Ellipta?

The Ellipta inhaler is designed to be simple to use:

  1. Slide the cover down until you hear a click. This loads one dose from the blister strip.
  2. Breathe out fully away from the mouthpiece.
  3. Place the mouthpiece between your lips and inhale quickly and deeply through your mouth.
  4. Hold your breath for about 3–4 seconds, then breathe out slowly.
  5. Close the cover. You don't need to shake or prime the inhaler.

Use it once daily, at the same time each day. Never use more than once per 24 hours. The dose counter on the front of the inhaler will show how many doses remain (starting at 30 for a new inhaler).

How Should Incruse Ellipta Be Stored?

Store Incruse Ellipta at room temperature (68°F–77°F / 20°C–25°C). Keep it in a cool, dry place away from direct heat and sunlight. Keep the inhaler inside its sealed foil tray until you're ready to use it. Once the foil tray is opened, the inhaler must be used within 6 weeks — even if it still has doses remaining. Write the date you opened it on the inhaler.

Who Should NOT Use Incruse Ellipta?

Incruse Ellipta is contraindicated in patients with:

  • Severe hypersensitivity to milk proteins (the inhaler contains lactose monohydrate with milk proteins — anaphylactic reactions have been reported)
  • Known hypersensitivity to umeclidinium or any ingredient in the formulation

Use with caution in patients with narrow-angle glaucoma, urinary retention, prostatic hyperplasia, or bladder neck obstruction.

What Are the Most Common Side Effects?

The most common side effects (occurring in ≥2% of patients in clinical trials) include nasopharyngitis (8%), upper respiratory tract infection (5%), cough (3%), arthralgia (2%), and pharyngitis (1%). Serious but uncommon side effects include paradoxical bronchospasm, urinary retention, worsening glaucoma, and anaphylaxis. See the full side effects guide for more detail.

How Much Does Incruse Ellipta Cost in 2026?

The retail price of Incruse Ellipta is approximately $350–$415 per 30-day inhaler. With the GSK "Pay No More Than $35" coupon, commercially insured patients pay as little as $35 per fill. GoodRx coupons can reduce the price to approximately $203.90. There is no generic version of Incruse Ellipta available as of 2026. For full savings details, see our Incruse Ellipta savings guide.

Finding Incruse Ellipta Near You

Not all pharmacies stock Incruse Ellipta. If you're having trouble locating it, use medfinder to find a pharmacy near you that can fill your prescription. medfinder contacts pharmacies in your area on your behalf and texts you the results.

Frequently Asked Questions

Incruse Ellipta (umeclidinium 62.5 mcg) is FDA-approved for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults, including chronic bronchitis and emphysema. It is used once daily to prevent COPD symptoms such as breathlessness, wheezing, cough, and chest tightness. It is not a rescue inhaler and should not be used for sudden breathing attacks.

Most patients notice improvements in breathing within 24 hours of the first dose, as the medication reaches peak effect within the first day of use. Incruse Ellipta works continuously over 24 hours to keep airways open. Maximum clinical benefit may take several weeks of consistent daily use.

No. Incruse Ellipta is not FDA-approved for the treatment of asthma. It is specifically indicated for COPD only. Other LAMA medications may be approved for use in asthma as add-on therapy, but Incruse Ellipta should not be used for asthma unless specifically directed by a physician in an off-label context.

If you miss a dose, take it as soon as you remember — unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue your regular schedule. Never take two doses within 24 hours. Incruse Ellipta should be used at the same time every day to maintain consistent bronchodilation.

No. Incruse Ellipta is not a steroid inhaler. It is a long-acting muscarinic antagonist (LAMA) — a type of bronchodilator. Inhaled corticosteroids (ICS) reduce airway inflammation, while LAMAs like Incruse Ellipta relax airway smooth muscle. Both types of inhalers may be used in COPD, but they work through completely different mechanisms.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Incruse Ellipta also looked for:

Tiotropium (Spiriva HandiHaler/Respimat)Aclidinium (Tudorza Pressair)Revefenacin (Yupelri)Anoro Ellipta (umeclidinium + vilanterol)

35,524 have already found their meds with Medfinder.

Start your search today.

35K+
5-star ratingTrusted by 35,524 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?